Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells

Conventional regimens have limited impact against non-small cell lung cancer (NSCLC). Current research is focusing on multiple pathways as potential targets, and this study investigated molecular mechanisms underlying the combination of the PKCβ inhibitor enzastaurin with the multitargeted antifolat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tekle, C, Giovannetti, E, Sigmond, J, Graff, J R, Smid, K, Peters, G J
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2008
Sujets:
Translational Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2528136/
https://ncbi.nlm.nih.gov/pubmed/18728666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604566
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires